Diagnostic Prediction Model for De Novo Metastatic Breast Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMarkusovszky University Teaching Hospital os County Vas

About this trial

The goal of this observational study is to create a tool to estimate the risk of macroscopic distant tumor spread in women with newly diagnosed breast cancer. The main question it aims to answer is:

• Can a model, which combines routine medical information collected at diagnosis, accurately predict if a patient has metastasis large enough to be found during systemic imaging? Researchers will review the past medical records of participants who were treated at a university hospital. Because this study looks at past data, participants will not be asked to do any new tasks, take new tests, or change their medical care.

Eligibility criteria

Qualifiers

Female sex, aged 18 years or older.

Newly diagnosed invasive breast cancer.

Case reviewed by the Multidisciplinary Tumour Board at the study site during the inclusion period (between October 1, 2018, and July 31, 2025).

No history of prior or synchronous invasive malignancies, except for synchronous bilateral breast cancer.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

925 Participants
are grouped into 1 trial group